Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: Further evidence that factor H regulates the classical complement pathway

Protein and Cell

Volumn 2, Issue 4, 2011, Pages 320-332

  Tan, Lee Aun ^a,b   Yang, Andrew C ^c,d   Kishore, Uday ^e,f   Sim, Robert B ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SUNY Downstate Medical Center   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

bacteria; C1q; complement; factor H; lipid A

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4B; COMPLEMENT FACTOR H; LIPID A; LIPOSOME; RADIOACTIVE IODINE; RECOMBINANT PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT FIXATION; CONTROLLED STUDY; DOWN REGULATION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; CHEMISTRY; ENZYME SPECIFICITY; IMMUNOLOGY; ISOTOPE LABELING; METABOLISM;

ESCHERICHIA COLI; NEGIBACTERIA;

BINDING, COMPETITIVE; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C4B; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, CLASSICAL; ESCHERICHIA COLI; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; LIPID A; LIPOSOMES; PROTEIN BINDING; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 80052145222     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-011-1029-y     Document Type: Article

References (52)

1. Albertí, S., Marqués, G., Hernández-Allés, S., Rubires, X., Tomás, J. M., Vivanco, F., and Benedí, V. J. (1996). Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect Immun 64, 4719-4725.
2. Arvieux, J., Reboul, A., Bensa, J. C., and Colomb, M. G. (1984). Characterization of the C1q receptor on a human macrophage cell line, U937. Biochem J 218, 547-555.
3. Bone, R. C. (1991). The pathogenesis of sepsis. Ann Intern Med 115, 457-469.
4. Bunse, R., and Heinz, H. P. (1993). Interaction of the capsular polysaccharide of Haemophilus influenzae type B with C1q. Behring Inst Mitt 93, 148-164.
5. Clas, F., Euteneuer, B., Stemmer, F., and Loos, M. (1989). Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria. Behring Inst Mitt 84, 236-254.
6. Charlesworth, J. A., Scott, D. M., Pussell, B. A., and Peters, D. K. (1979). Metabolism of human beta 1H: studies in man and experimental animals. Clin Exp Immunol 38, 397-404.
7. Cooper, N. R., and Morrison, D. C. (1978). Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol 120, 1862-1868.
8. Díaz, A., Ferreira, A., and Sim, R. B. (1997). Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol 158, 3779-3786.
9. Dillon, S. P., D'souza, A., Kurien, B. T., and Scofield, R. H. (2009). Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum. Biotechnol J 4, 1210-1214.
10. Dodds, A. W., Sim, R. B., Porter, R. R., and Kerr, M. A. (1978). Activation of the first component of human complement (C1) by antibody-antigen aggregates. Biochem J 175, 383-390.
11. Edey, M., Strain, L., Ward, R., Ahmed, S., Thomas, T., and Goodship. T. H. (2009). Is complement factor H a susceptibility factor for IgA nephropathy? Mol Immunol 46, 1405-1408.
12. Eisenschenk, F. C., Houle, J. J., and Hoffmann, E. M. (1999). Mechanism of serum resistance among Brucella abortus isolates. Vet Microbiol 68, 235-244.
13. Fearon, D. T. (1978). Regulation by membrane sialic acid of 1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci U S A 75, 1971-1975.
14. Gaboriaud, C., Juanhuix, J., Gruez, A., Lacroix, M., Darnault, C., Pignol, D., Verger, D., Fontecilla-Camps, J. C., and Arlaud, G. J. (2003). The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 278, 46974-46982.
15. Gulati, S., Cox, A., Lewis, L. A., Michael, F. S., Li, J., Boden, R., Ram, S., and Rice, P. A. (2005). Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci. Infect Immun 73, 7390-7397.
16. de Haas, C. J., van Leeuwen, E. M., van Bommel, T., Verhoef, J., van Kessel, K. P., and van Strijp, J. A. (2000). Serum amyloid P component bound to gram-negative bacteria prevents lipopoly-saccharide-mediated classical pathway complement activation. Infect Immun 68, 1753-1759.
17. Ingram, G., Hakobyan, S., Hirst, C. L., Harris, C. L., Pickersgill, T. P., Cossburn, M. D., Loveless, S., Robertson, N. P., and Morgan, B. P. (2010). Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain 133, 1602-1611.
18. Jack, D. L., and Turner, M. W. (2003). Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 31, 753-757.
19. Joiner, K. A., Schmetz, M. A., Sanders, M. E., Murray, T. G., Hammer, C. H., Dourmashkin, R., and Frank, M. M. (1985). Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci U S A 82, 4808-4812.
20. Joiner, K. A., Grossman, N., Schmetz, M., and Leive, L. (1986). C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol 136, 710-715.
21. Kishore, U., Gupta, S. K., Perdikoulis, M. V., Kojouharova, M. S., Urban, B. C., and Reid, K. B. M. (2003). Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol 171, 812-820.
22. Kishore, U., Ghai, R., Greenhough, T. J., Shrive, A. K., Bonifati, D. M., Gadjeva, M. G., Waters, P., Kojouharova, M. S., Chakraborty, T., and Agrawal, A. (2004a). Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett 95, 113-128.
23. Kishore, U., Gaboriaud, C., Waters, P., Shrive, A. K., Greenhough, T. J., Reid, K. B. M., Sim, R. B., and Arlaud, G. J. (2004b). C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 25, 551-561.
24. Kojouharova, M. S., Gadjeva, M. G., Tsacheva, I. G., Zlatarova, A., Roumenina, L. T., Tchorbadjieva, M. I., Atanasov, B. P., Waters, P., Urban, B. C., Sim, R. B., et al. (2004). Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction. J Immunol 172, 4351-4358.
25. Kraiczy, P., and Würzner, R. (2006). Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 43, 31-44.
26. Kubens, B. S., Nikolai, S., and Opferkuch, W. (1989). A third mechanism of serum resistance in Escherichia coli. Zentralbl Bakteriol 271, 222-230.
27. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
28. Latsch, M., Stemmer, F., and Loos, M. (1992). Purification and characterization of LPS-free porins isolated from Salmonella minnesota. FEMS Microbiol Lett 69, 275-281.
29. Loos, M., and Clas, F. (1987). Antibody-independent killing of gram-negative bacteria via the classical pathway of complement. Immunol Lett 14, 203-208.
30. Maruvada, R., Blom, A. M., and Prasadarao, N. V. (2008). Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 124, 265-276.
31. McAleer, M. A., and Sim, R. B. (1993). The complement system. In: Activators and Inhibitors of Complement. Sim, R. B. ed. Dordrecht, Netherlands: Kluwer. 1-15.
32. Meri, S., and Pangburn, M. K. (1990). Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A 87, 3982-3986.
33. Merino, S., Vilches, S., Canals, R., Ramirez, S., and Tomás, J. M. (2005). A C1q-binding 40 kDa porin from Aeromonas salmonicida: cloning, sequencing, role in serum susceptibility and fish immunoprotection. Microb Pathog 38, 227-237.
34. Morrison, D. C., and Kline, L. F. (1977). Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 118, 362-368.
35. New, R. C. C. (1990). Preparation of liposomes, In: Liposomes - a practical approach. New, R. C. C. (ed.). Oxford, U. K. IRI Press, 3-104.
36. Reid, K. B., and Porter, R. R. (1976). Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J 155, 19-23.
37. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., et al. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8, 217-225.
38. Ripoche, J., Day, A. J., Harris, T. J., and Sim, R. B. (1988). The complete amino acid sequence of human complement factor H. Biochem J 249, 593-602.
39. Roumenina, L. T., Rouseva, M., Zlatarova, A., Kolev, M., Ghai, R., Olova, N., Gadjeva, M., Agrawal, A., Mantovani, A., Bottazzi, B., et al. (2006). Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational analyses using recombinant globular regions of C1q A, B and C chains. Biochemistry 45, 4093-4104.
40. Schneider, M. C., Exley, R. M., Chan, H., Feavers, I., Kang, Y. H., Sim, R. B., and Tang, C. M. (2006). Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176, 7566-7575.
41. Shang, S. Q., Chen, G. X., Shen, J., Yu, X. H., and Wang, K. Y. (2005). The binding of MBL to common bacteria in infectious diseases of children. J Zhejiang Univ Sci B 6, 53-56.
42. Sim, R. B., and Malhotra, R. (1994). Interactions of carbohydrates and lectins with complement. Biochem Soc Trans 22, 106-111.
43. Sim, E., and Sim, R. B. (1983). Enzymic assay of C3b receptor on intact cells and solubilized cells. Biochem J 210, 567-576.
44. Sim, R. B., Day, A. J., Moffatt, B. E., and Fontaine, M. (1993). Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol 223, 13-35.
45. Stewart, J. C. (1980). Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104, 10-14.
46. Tan, L. A., Yu, B., Sim, F. C., Kishore, U., and Sim, R. B. (2010). Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell 1, 1033-1049.
47. van den Berg, R. H., Faber-Krol, M. C., van de Klundert, J. A., van Es, L. A., and Daha, M. R. (1996). Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. J Immunol 156, 4466-4473.
48. Weiler, J. M., Daha, M. R., Austen, K. F., and Fearon, D. T. (1976). Control of the amplification convertase of complement by the plasma protein β1H. Proc Natl Acad Sci U S A 73, 3268-3272.
49. Whaley, K., and Ruddy, S. (1976). Modulation of the alternative complement pathways by β1H globulin. J Exp Med 144, 1147-1163.
50. Ying, S. C., Gewurz, A. T., Jiang, H., and Gewurz, H. (1993). Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J Immunol 150, 169-176.
51. Zipfel, P. F., Würzner, R., and Skerka, C. (2007). Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44, 3850-3857.
52. Zohair, A., Chesne, S., Wade, R. H., and Colomb, M. G. (1989). Interaction between complement subcomponent C1q and bacterial lipopolysaccharides. Biochem J 257, 865-873.